Diabetes Mellitus, Type 2 — Safety of Liraglutide in Pediatric Patients With Type 2 Diabetes
Citation(s)
Liraglutide: A Randomized, Double-blind, Placebo Controlled Trial to Assess Safety/Tolerability, Pharmacokinetics & Pharmacodynamics of Liraglutide in Pediatric (10-17 Years Old) With Type 2 Diabetes